top of page

microsurgery.be groep

Openbaar·12 leden

Ervaring met rollen en levenscyclus in DPMM

Hallo forumleden. Ik ben momenteel betrokken bij meerdere projecten en merk dat ik behoefte heb aan een duidelijker structuur in mijn aanpak. De Dynamic Project Management Method Foundation lijkt interessant vanwege de focus op rollen, verantwoordelijkheden en de projectlevenscyclus. Toch twijfel ik of het foundation-niveau voldoende praktisch is om meteen toe te passen. Vooral onderwerpen zoals planning, controle en veranderingsmanagement zijn voor mij belangrijk. Daarnaast wil ik weten hoe zwaar het examen is en of twee dagen training voldoende voorbereiding bieden. Heeft iemand recente ervaring met deze cursus?

11 weergaven

Hoi, ik heb deze training recent gevolgd en kan mijn ervaring delen. Tijdens mijn DPMM Foundation training werden in twee dagen van 14 contacturen alle kernonderdelen van de methode systematisch behandeld. De focus lag op rollen en verantwoordelijkheden binnen projecten, het projectlevenscyclusmodel en onderwerpen zoals planning, controle, risicobeheer en kwaliteitsmanagement. Ook veranderingsmanagement en communicatie kwamen uitgebreid aan bod. De cursus bereidt direct voor op het officiële EXIN-examen met 40 meerkeuzevragen en een tijdsduur van 60 minuten. Om te slagen moet je minimaal 65 procent correct beantwoorden en de examenvoucher is inbegrepen bij de training. Het lesmateriaal is officieel geaccrediteerd.

Optical Coherence Tomography (OCT)

Introduction

OCT measures the echo time delay and intensity of backscattered light to create two- and three-dimensional images. Because light travels extremely quickly, OCT uses interferometry to detect small changes in reflected light and convert them into detailed internal images of tissues.

Its ability to visualize tiny structural changes makes OCT essential for early disease detection, especially in the retina, cornea, blood vessels, and skin.

How OCT Works

OCT systems typically include:

  1. Light Source


5 weergaven

Bronchitis Market Size: Global Expansion and Product Adoption

The Bronchitis Market Size highlights the overall valuation and growth potential across regions and product types. With a market value of USD 14.83 billion in 2024, it is projected to reach USD 22.63 billion by 2032, exhibiting a CAGR of 7.43%. The increasing prevalence of respiratory diseases, including both acute and chronic bronchitis, is driving the market's expansion.

Pharmacological treatments, including bronchodilators, corticosteroids, and antibiotics, are gaining prominence. Hospitals, clinics, and home-care applications serve as key end-user segments. Hospitals and clinics dominate adoption due to their ability to provide professional guidance and monitor treatment efficacy. Home care is growing in popularity due to the convenience and accessibility of treatment options.

Technological innovations in drug formulations, including personalized therapies, targeted delivery systems, and combination treatments, enhance efficacy and reduce side effects, further boosting market adoption. Consumer awareness campaigns and social media influence also drive interest in clinically validated bronchitis treatments.

Regionally, North…

3 weergaven

Alopecia Drugs Market Overview: Growth and Market Size

The Alopecia Drugs Market Overview provides insights into the market's expansion, driven by factors such as genetics, hormonal imbalances, and stress. The market is projected to grow from USD 11.8 billion in 2024 to USD 23.34 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.95% during the forecast period (2024 - 2032). This growth is attributed to the increasing prevalence of alopecia, advancements in drug development, and rising consumer awareness of treatment options.

3 weergaven
bottom of page